Sant’Andrea University Hospital in Rome has embedded Powerful Medical’s AI ECG analysis into its emergency heart-attack pathway, automatically notifying cardiology when a recording is flagged as high risk. Powerful Medical says clinicians opened those reports in a median of under 17 seconds after the alert: the notable development is the connection between detection and action, not simply another diagnostic app.
Powerful Medical Watch analysis
What happened
In its 7 October case study, Powerful Medical describes a pathway that screened 5,629 patients between 13 February and 13 August 2026. ECG recordings move automatically from the hospital’s existing equipment to PMcardio for analysis, with high-risk findings delivered through its established staff communication system.
The company reports 138 STEMI alerts, with 69% of alerts generated automatically without a clinician initiating the analysis. It also reports a median door-to-balloon time of 56 minutes, measuring the interval from hospital arrival to the procedure used to reopen a blocked artery. That is a reported treatment-time measure, not evidence by itself that AI shortened it.
The system also flags STEMI-equivalent patterns associated with coronary occlusion, including cases that do not meet conventional ST-segment elevation criteria. Powerful Medical says these represented 64% of the STEMI alerts. The treating clinical team still decides whether to activate the catheterisation laboratory.
Why it matters
An ECG can be recorded promptly and still wait for someone to interpret it. This deployment targets that gap: analysis and notification happen in the background, rather than depending on a busy clinician remembering to open another application.
That makes the operational design worth attention. The pathway connects an AI finding to the specialist who can assess it, while preserving clinical authority over treatment. A fast result is useful; a fast result sitting unnoticed in an inbox is rather less so.
Our read
This is a meaningful example of clinical AI becoming part of a working hospital pathway. The useful lesson for health-service teams is to evaluate the whole chain, from recording acquisition to specialist review, rather than judging the model in isolation.
The evidence supports an attributed account of deployment and reported timings, not a claim that the system reduces deaths or outperforms usual care. The announcement supplies no before-and-after comparison establishing a treatment benefit, and rapid report opening is not the same as rapid treatment.
The source relationship matters, too. Professor Emanuele Barbato, the hospital’s director of cardiology quoted in the account, also sits on Powerful Medical’s Scientific Advisory Board. This is a vendor-published case study with a disclosed connection, not an independent clinical verdict. Powerful Medical’s Sant’Andrea deployment account sets out the workflow and reported figures.
What to watch
- Comparative treatment-time and patient-outcome data, rather than report-opening speed alone.
- How missed cases and false alerts are measured across all screened patients.
- Whether the same workflow performs reliably in hospitals with different staffing and equipment.
- How cardiology teams manage alert volume while retaining the final treatment decision.
Discussion spark: Should hospitals adopt automated AI-to-cardiology alerts on evidence of faster specialist review, or require comparative patient-outcome data before changing the emergency pathway?
Sources and evidence
not affiliated with or endorsed by Powerful Medical